Prs30 Budget Impact Analysis of a Single-Inhaler Triple Therapy (Trelegyã‘) Versus Dual Combination and Multiple-Inhaler Triple Therapy for the Treatment of Patients With Copd Moderate to Very-Severe From Public Health System Perspective in Chile

Abstract

Objectives: Developed countries have seen an increase in the prevalence of asthma. The treatment of its main symptoms and its increasing prevalence have become major challenges for health care financers and governments. Our aim was to determine the annual health insurance treatment cost of asthma in Hungary. Methods: Data were derived from the financial database of the NHIFA, for the year 2018. Data S354 VALUE IN HEALTH - MAY 2020